Free Trial

Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts

Ironwood Pharmaceuticals logo
$0.90 +0.02 (+1.92%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.92 +0.02 (+2.02%)
As of 08/8/2025 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ironwood Pharmaceuticals Earnings Summary

Ironwood Pharmaceuticals announced Q2 2025 earnings on August 7, 2025, reporting an EPS of $0.14, which topped analysts' consensus estimates of -$0.02 by $0.16. Quarterly revenue was reported to be $85.24 million, above analyst estimates of $62.02 million. With a trailing EPS of -$0.05, Ironwood Pharmaceuticals' earnings are expected to grow 150.00% next year, from $0.10 to $0.25 per share.

Upcoming Q3
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(Aug. 7)
-$0.02
Actual EPS
(Aug. 7)
$0.14 Beat By $0.16
Actual Revenue
(Aug. 7)
$85.24M

Q2 2025 Earnings Resources

IRWD Upcoming Earnings

Ironwood Pharmaceuticals' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Get Ironwood Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ironwood Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IRWD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRWD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ironwood Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20252-$0.06$0.01-$0.03
Q2 20252-$0.05-$0.04-$0.05
Q3 20252$0.08$0.11$0.10
Q4 20252$0.16$0.24$0.20
FY 2025 8 $0.13 $0.32 $0.23
Q1 20261$0.04$0.04$0.04
Q2 20262$0.06$0.11$0.09
Q3 20262$0.11$0.11$0.11
Q4 20261$0.12$0.12$0.12
FY 2026 6 $0.33 $0.38 $0.36
Q1 20271$0.02$0.02$0.02

Ironwood Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
8/7/2025Q2 2025-$0.02$0.14+$0.16$0.14$62.02M$85.24M
5/7/2025Q1 2025-$0.05-$0.14 -$0.09-$0.23$67.02M$41.14M
2/27/2025Q4 2024$0.10$0.02 -$0.08$0.02$93.85M$90.55M
11/7/2024Q3 2024$0.09$0.02 -$0.07$0.02$91.22M$91.60M
5/9/2024Q1 2024$0.18-$0.02 -$0.20-$0.01$105.75M$74.90M
11/9/2023Q3 2023$0.17$0.12 -$0.05$0.15$112.90M$113.74M

Ironwood Pharmaceuticals Earnings - Frequently Asked Questions

Ironwood Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on IRWD's earnings history.

Ironwood Pharmaceuticals updated its FY 2025 earnings guidance on Thursday, August, 7th. The company issued revenue guidance of $260.0 million-$290.0 million, compared to the consensus revenue estimate of $270.6 million.

In the previous quarter, Ironwood Pharmaceuticals (NASDAQ:IRWD) reported $0.14 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.02) by $0.16. Learn more on analysts' earnings estimate vs. IRWD's actual earnings.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $308.52 million.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of $880,000.00. IRWD has generated -$0.05 earnings per share over the last four quarters.

Ironwood Pharmaceuticals' earnings are expected to grow from $0.10 per share to $0.25 per share in the next year, which is a 150.00% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:IRWD) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners